Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 11 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 2841.14 | 578 / 578 | 90% | 8.00 | 1036 / 1155 |
breast | 94% | 760.03 | 430 / 459 | 95% | 41.10 | 1066 / 1118 |
pancreas | 99% | 955.96 | 325 / 328 | 89% | 11.31 | 159 / 178 |
bladder | 90% | 1470.52 | 19 / 21 | 91% | 18.22 | 457 / 504 |
thymus | 99% | 1076.67 | 644 / 653 | 82% | 13.12 | 495 / 605 |
kidney | 100% | 1048.49 | 89 / 89 | 77% | 6.23 | 697 / 901 |
intestine | 81% | 1200.95 | 783 / 966 | 81% | 6.13 | 427 / 527 |
stomach | 79% | 434.25 | 284 / 359 | 81% | 6.26 | 233 / 286 |
esophagus | 82% | 431.47 | 1181 / 1445 | 73% | 5.14 | 133 / 183 |
uterus | 59% | 263.62 | 101 / 170 | 83% | 8.55 | 383 / 459 |
skin | 71% | 546.32 | 1281 / 1809 | 65% | 6.79 | 309 / 472 |
prostate | 85% | 591.93 | 208 / 245 | 38% | 2.03 | 191 / 502 |
brain | 28% | 114.36 | 728 / 2642 | 85% | 6.98 | 599 / 705 |
liver | 78% | 378.38 | 176 / 226 | 30% | 2.67 | 123 / 406 |
ovary | 37% | 138.04 | 67 / 180 | 70% | 4.07 | 300 / 430 |
lymph node | 0% | 0 | 0 / 0 | 100% | 49.11 | 29 / 29 |
peripheral blood | 100% | 24579.38 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 10319.44 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 45.57 | 1 / 1 |
adipose | 96% | 880.91 | 1160 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 11.54 | 42 / 45 |
adrenal gland | 69% | 318.37 | 178 / 258 | 9% | 0.47 | 21 / 230 |
heart | 62% | 277.90 | 536 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 46% | 303.43 | 616 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 36% | 1.88 | 29 / 80 |
muscle | 4% | 12.44 | 32 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046847 | Biological process | filopodium assembly |
GO_0051056 | Biological process | regulation of small GTPase mediated signal transduction |
GO_0008360 | Biological process | regulation of cell shape |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0043087 | Biological process | regulation of GTPase activity |
GO_0007010 | Biological process | cytoskeleton organization |
GO_0001726 | Cellular component | ruffle |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0030027 | Cellular component | lamellipodium |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005737 | Cellular component | cytoplasm |
GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
GO_0031267 | Molecular function | small GTPase binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | FGD3 |
Protein name | FYVE, RhoGEF and PH domain-containing protein 3 (Zinc finger FYVE domain-containing protein 5) FGD3 |
Synonyms | ZFYVE5 |
Description | FUNCTION: Promotes the formation of filopodia. May activate CDC42, a member of the Ras-like family of Rho- and Rac proteins, by exchanging bound GDP for free GTP. Plays a role in regulating the actin cytoskeleton and cell shape (By similarity). . |
Accessions | Q5JSP0 ENST00000416701.6 [Q5JSP0-3] ENST00000468206.6 [Q5JSP0-1] ENST00000337352.10 [Q5JSP0-1] ENST00000375482.8 [Q5JSP0-1] A0A2X0U4Q9 ENST00000467786.1 [Q5JSP0-2] |